IFIH1 and lung disorder: For SARS-CoV NSP16 mutants, loss of MDA5 had no major effect on restoring replication in vitro or in vivo (Menachery et al., 2014a, 2014b); yet, MDA5−/− mice had restored lung disease with NSP16-mutant virus infection.